ASLAN Pharmaceuticals (ASLAN Pharmaceuticals) Other Current Payables : $2.35 Mil (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is ASLAN Pharmaceuticals Other Current Payables?

ASLAN Pharmaceuticals's Other Current Payables for the quarter that ended in Mar. 2024 was $2.35 Mil.

ASLAN Pharmaceuticals's quarterly Other Current Payables increased from Sep. 2023 ($2.33 Mil) to Dec. 2023 ($3.08 Mil) but then declined from Dec. 2023 ($3.08 Mil) to Mar. 2024 ($2.35 Mil).

ASLAN Pharmaceuticals's annual Other Current Payables declined from Dec. 2021 ($2.68 Mil) to Dec. 2022 ($2.33 Mil) but then increased from Dec. 2022 ($2.33 Mil) to Dec. 2023 ($3.08 Mil).

ASLAN Pharmaceuticals Other Current Payables Historical Data

The historical data trend for ASLAN Pharmaceuticals's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ASLAN Pharmaceuticals Other Current Payables Chart

ASLAN Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Current Payables

Get a 7-Day Free Trial

2.85

3.54

2.68

2.33

3.08

ASLAN Pharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Current Payables	Get a 7-Day Free Trial															2.33	2.41	2.33	3.08	2.35

ASLAN Pharmaceuticals Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

ASLAN Pharmaceuticals Other Current Payables Related Terms

Thank you for viewing the detailed overview of ASLAN Pharmaceuticals's Other Current Payables provided by GuruFocus.com. Please click on the following links to see related term pages.

ASLAN Pharmaceuticals (ASLAN Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ASLAN Pharmaceuticals Ltd (NAS:ASLN) » Definitions » Other Current Payables

Comparable Companies

Traded in Other Exchanges

N/A

Address

3 Temasek Avenue, Level 18, Centennial Tower, Singapore, SGP, 039190

Website

https://www.aslanpharma.com

ASLAN Pharmaceuticals Ltd is a clinical-stage immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients. The company is evaluating ASLAN004, a potential first-in-class antibody targeting the IL-13 receptor, in atopic dermatitis, and ASLAN003, a potent oral inhibitor of DHODH, which is being developed for autoimmune disease.